Medicine Man Technologies, Inc. Provides Guidance for A Fourth-Quarter 2022
August 11, 2022 at 04:30 pm
Share
Medicine Man Technologies, Inc. provided its guidance for a fourth-quarter 2022 annualized run rate, which excludes transactions that are announced but not closed. Fourth Quarter 2022 revenue annualized run rate is projected to be $175 million to $200 million.
Medicine Man Technologies, Inc., operating as Schwazze, is a vertically integrated multi-state cannabis operator. The Companyâs business involves the cultivation, manufacturing, distribution and retail sale of cannabis and cannabis-related products. The Company sells products it manufactures and cultivates and a variety of other cannabis goods through wholly owned retail stores, licensing arrangements, and/or third-party operators and retailers. It has three segments: Retail, Wholesale and Other. The Retail segment consists of retail locations for the sale of cannabis products. The Wholesale segment consists of manufacturing, cultivation and sale of both wholesale cannabis and non-cannabis products. The Other segment encompasses the Companyâs general corporate operations, in-store advertisements and certain vendor promotions. It has operations in Colorado and New Mexico. The Company owns and operates 63 retail dispensaries, six cultivation facilities and three manufacturing facilities.
MEDICINE MAN TECHNOLOGIES, INC. 
